WELL Health Technologies

WELL Health to Present at Upcoming 24th Annual CIBC Western Institutional Investor Conference

Vancouver, BC – January 19, 2021 – WELL Health Technologies Corp. (TSX: WELL) (“WELL” or the “Company”), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, is pleased to announce Hamed Shahbazi, Chairman and CEO, will be presenting at the following upcoming virtual conference:

24th Annual CIBC Western Institutional Investor Conference

on Friday, January 22, 2021,

at 8:20am PST (11:20am EST)

in Virtual Auditorium Four

Now in its 24th year, the CIBC Western Insititutional Investor Conference is a multi-sector virtual conference connecting the investor community with senior company executives.  Please contact your CIBC representative to register for the event.

WELL HEALTH TECHNOLOGIES CORP.

Per: “Hamed Shahbazi”

Hamed Shahbazi

Chief Executive Officer, Chairman and Director

About WELL Health Technologies Corp.

WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health.  As such, WELL owns and operates 27 primary healthcare clinics, is Canada’s third largest digital Electronic Medical Records (EMR) supplier serving approximately 2,200 healthcare clinics, operates a high quality telehealth services in both Canada and the United States and is a provider of digital health, billing and cybersecurity related technology solutions.  WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy.  WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL”.  To access the Company’s telehealth service, visit: tiahealth.com, and for corporate information, visit: www.well.company.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information

Pardeep S. Sangha

VP Corporate Strategy and Investor Relations

investor@well.company

604-572-6392

up-white